Millennium Management’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.7M Buy
1,502,724
+1,245,875
+485% +$1.41M ﹤0.01% 2755
2025
Q1
$375K Buy
+256,849
New +$375K ﹤0.01% 3408
2024
Q4
Sell
-258,002
Closed -$722K 4046
2024
Q3
$722K Buy
258,002
+78,378
+44% +$219K ﹤0.01% 3103
2024
Q2
$419K Sell
179,624
-21,846
-11% -$50.9K ﹤0.01% 3276
2024
Q1
$901K Sell
201,470
-1,717,544
-90% -$7.68M ﹤0.01% 3017
2023
Q4
$6.16M Buy
1,919,014
+1,794,616
+1,443% +$5.76M ﹤0.01% 1777
2023
Q3
$394K Sell
124,398
-85,368
-41% -$271K ﹤0.01% 3356
2023
Q2
$1.04M Sell
209,766
-793,230
-79% -$3.94M ﹤0.01% 2892
2023
Q1
$4.96M Sell
1,002,996
-2,272,128
-69% -$11.2M ﹤0.01% 1929
2022
Q4
$20.6M Buy
3,275,124
+1,878,645
+135% +$11.8M 0.01% 989
2022
Q3
$15.1M Buy
1,396,479
+619,607
+80% +$6.69M 0.01% 1148
2022
Q2
$8.86M Buy
776,872
+205,666
+36% +$2.34M 0.01% 1646
2022
Q1
$5.2M Buy
571,206
+416,173
+268% +$3.79M ﹤0.01% 2244
2021
Q4
$2.31M Sell
155,033
-73,590
-32% -$1.1M ﹤0.01% 2850
2021
Q3
$5.88M Sell
228,623
-276,672
-55% -$7.11M ﹤0.01% 2028
2021
Q2
$13.2M Buy
505,295
+222,330
+79% +$5.8M 0.01% 1144
2021
Q1
$9.99M Sell
282,965
-142,517
-33% -$5.03M 0.01% 1382
2020
Q4
$10.7M Buy
425,482
+357,234
+523% +$9.02M 0.01% 1267
2020
Q3
$2.57K Sell
68,248
-138,931
-67% -$5.24K ﹤0.01% 1878
2020
Q2
$8.87M Buy
207,179
+155,678
+302% +$6.67M 0.01% 1018
2020
Q1
$1M Sell
51,501
-20,392
-28% -$396K ﹤0.01% 1981
2019
Q4
$1.87M Buy
+71,893
New +$1.87M ﹤0.01% 2160
2019
Q3
Hold
0
3464